`IrriprovetheOuafityol'Cardi-ovmflerCarein Hospitalized Patientawiih
`mascara
`mmmmmmmmMamomlmmm
`MINCE
`mummmompmrenmmmmmmmm
`Inmmlm
`EtecflonbAtertaioerThmmboenmoiiamProphytaxiafieduoefiatea
`otProirIntalDWendPEAntongHoepttalmdPatienta1AHmdornizred
`WTfldmmflfi
`memorandum-.mmmarw
`lriaightafrurn lhaMuIfi-Efltnicsmyolmm. 377B
`Emmmrnmmmmmwmmm
`Obesity.”
`Furl-lasareMoreHeoietamtoSmafltanMalea:Gander-Specflicfloie
`oil-llFinVerttrIouiarRerrIodelhg.51D
`Wrmmmhmmmeumm
`t-tawail.3809
`Fair-Year Foilew-Upoi'lheMuIiioenterFlctotCoaching Patientaon
`mmmmmmnsmrsrmmm
`CDACHProgramKeepaPattarrt-OutotHaapttalJm
`WMMMWMMJWQ
`MUWWWMWMWWM
`RECEPTOR [GI-15H. Ghrelkifleceptor‘] Gemini-lumen Obesity. 3737
`Global Rial: FactorAaaemtent Morlredly Undoneatlrnataa Subclinical
`WWWHWWWJBW
`Immommmwmmmmm
`DiamthSAdultawlthMetaboltcSyndmm.Diabetaa.md
`WWMM.244$
`ImpactoEObeeHyonOualflyofutehPe‘flentewttnMvancedHeart
`same-115
`mmmwnmmmmrnwmm
`MWMonflhPaflaPrwecMStudyLflfia
`WIWWWWMWMW
`Scum LipidstThePFlEMlEFt Trial. 3573
`Mediterranear'i-irrapired Diet Fteducea the Nurnberol Leukocytes and
`PlateleteandDacrmVaacuhrErtdofi‘ralialGrMhFectothealthy
`emcee:
`Hemmemmmrmmmwm
`IWWIWMWWM
`ManolonalfilocldnganfibodymmCC-Ctiemokinefiecemorz
`Inhl‘bttsAtheruederotlc LeatornDeveloprnentin ApoE‘Knockart Mice.
`Baa
`WWWWWIUWWWN
`WRBkYmmgAayniptornaflcMJMiSTDfi
`OptimalflioodpreewacontrolforlhePrevenflonolAtialdelafion.
`3548
`Oral D-itF Dramatically Synergieeawith Oral Pravaetetin toFteduce
`WHADDENUII Him. 173
`Pakn-haldDigItaiAeeletflTtaa‘thuiodlcPhyatoianFeedbaok
`DmcmmeNolnmtalVdueinmLm-cnmfioale.
`3702
`PDAYHiekScorePredictaCoronaryAnuyCalcluminYomgMuitezThe
`CARDIASMy.3665
`PWWMWMHWW.M
`Hmwreslaanmen:ThaWomen'aI-Iaalthlnitlative
`WM.3§70
`Population ImplicatioriaotMore AggraeiveLow—Denaity Llpcprotein
`Choieflet‘oi TreatmentGoala in 'High-Riair' ArrrarlcanMJIta: NHANES
`1999-2000.:ar01
`wmmnyrnmmormcmnmswumuangmr
`Dmgi4DJScore:HIakSuaHficationByDiedtangaMedicaflon.2345
`derwmwmmmh
`the Matti-Canter Unauetairied Tachycardia Trial. 2358
`Preoperative StatinTherapy tanaeociated with Fteduced Cardiac Mortality
`Followingmeryfirteryflypasaamflalm.m
`PrevalelmandTraatrnmtotDyalpldemiaAmonngmmfltDiabetee
`htheUnitadStatee1999-2ODD.3B&2
`Prevention OfCardiovaacular EmteByPerindoprll In Patients With Stable
`GomeryDiaeeaaDneeNotDapendOnBloodPresmN‘dlle
`Reduction-Heaths FrornTheEUHOPA Study. 2919
`RaoieIDilterericeainUpidManagementandCarcicuaeoularCutoon-iee
`AmongPefimtaWCaomMa-yflmmdydihem
`Lipid Managarnerrlin Coronary MaryDieeaselALMlCAD} Study. 3779
`Randomized Controlled TrielofSpecianzed Lipid Clinic versus
`Conventional CaraManagementoi' Hyperfipidemia in Patients with
`CoronaryMaryDlaeeee:FteewtaoftheActiyeUpidManagememin
`mmmmmmmem
`RegularExerciaeHeduceeMerialBloodPreseureatRestandCunng
`Exercise in Freed-loci Gillan-m: az-Year Clueter-Flenciorrrized
`CamfledTfiaLGSBQ
`fieguiatlonO‘IEndotheiiai Progenitor Geila ByFtu-‘inlng ExercIeeOI'
`Diflerei'tt DtxafionAnd intensity In Healthy Suhiects. 3572
`Riskr'BenefltAnaIyaiaotHyveflcaiemleon Clinical Outcomes inEPHESUS.
`3340
`
`ill-1049
`W index
`Subop‘timaltteeoi'Eifldenmd-baaed MedicatioreBeioreMyooan-lial
`InfmflonAmongPeflentawlfliandmeiebeteeWM:
`Obaarwltomfru‘ntheflafionel RaglatryotMyocardlellnfarction lNFtMi'l
`4.3849
`WdemPatlentethypemholmnienom
`aBmd-NueatoaGenuicGholeeteroI-Lmhg Drug.3781
`TargeungC-reaofiveprotein:ANoveiModaltorSmdyingttaSynthesie
`andaNoveiKeyPatnitrayorrtaTreneoriprionaIRegulationinHumen
`Hepatocytaa.1206
`UaectEyidanoe—BasedThorwleahPaflenteMthChmnicKidneyDtaeeae
`mmmmmwwmmmm
`WEE
`Vega] HFI Regulation in Enhanced with Intervet'itiot'ieto Reduce
`PsychalagIcaISIreeeanoDepreeaiorteMeta-Anamm
`Vamflu-ProgmitorCalleinsmPaflmtaMthCoronaryAmryDiaeeae:
`HmiteottheEndofinflalProgeritorCethorcnuyMeryDtaaaae
`{EPCADtStudy.2379
`Whid'listheMoetAcointeSUokerdicfionSoltemehAflalfibrflW
`PatienteTreatedwthnuooagulentflAOompar-taooofsmek
`31ratil'icetion3daernaa.3616
`
`Prophetic
`'WarrantyTima'oraNormalstreaeEchocardlowathetientatMfli
`History or Myocardial Infarction. 2913
`B-Biocker Therapy Intolerance in iachernic Cardiomlooeeiy ta Predictive ct
`HIgherCardlac Mortality Rate arterCudiao Fleeyncttrmizaticn‘lharepy.
`2264
`Preoperative Prediction of Long-Term Survival Foiloinrlrig Coronary Artsy
`Bypass Grafting in Patient with Low Let! Vent-1min: Election Fraction:
`The HAVOC Score. 1956
`AWfiwlatelmpedaneeCardiogi-aphy CompoeiteScoroCanPredctthe
`Committed MajorHeart Failure Emts: the PHEDICTStudy.2775
`MortedMyocardiellMercfionmbaanceotaSipnifimEnzymeFfleem
`Fb-hotyeteaaaPredictorormeetntareflmAreanmtorearty
`Intervention. 2517
`Activated Factor )ill Predicts Troponin-T Positive Cardiac Events at 30
`Days Follow-Up after Hospitalization with Acute cram Pain. 2128
`mwmmommeemmm
`endLDngTermMortalHylnPetiemaaflarAcuteMyocudldmfimin
`the Conternporuy Primary Nigiopiaety Era. 1943
`mmtarIVefla‘lion otSuddenCardlecDeethin Patiet'l‘lewith
`Obeeucttve Sleep Apnea. 3777
`MEleva‘tedBIoodUreaN‘mogen LevelleAmintadwitl-rh’nreaaed
`Mortality independent oi Serum Craatinine Among Patienta with
`Unatettla Corona-y Syndrmtea. 3235
`Analysis at N-tarrnirtal pro-Brain Matriurettc Peptide and C-I'eauthre Protein
`improves Flick Stratification in Stable and Unstable Goruwy Artery
`Diaeaaa, 2123
`mmmmrsemmwmmmmm
`lechenicEventslnPeflenteWfiinieelWThaWAG
`Cohort. 2050
`AnxielyardLowParception oi' Social Supponhrel'ldeperidentPredictore
`olHeecln'Iisaion in Patients HoaptlalizedwlthHaaflfiMflSO
`mvmnmmmrmmsmrnmmmmmc
`StenoaieAeaocietedt'iimSeverePumonuyHypertnaionJSST
`mrmmmcmmammwmwmm
`Suspected Myocardial lacherriie?l\fieportfrdmflteWornan's Iaohemitt
`Syndrome Evaluation. 3320
`_
`Assessment 01 Left Ventricular Dyeeyncrltony with Tieem Doppler Imaging
`Predicts Prognosis following Cardiac Heeyndironlzatlori Therapy. 2023
`Amdation oI'DRS Duaticnerid Otmomuhfteruyocardiatinfarotlon:
`The VALIANT Trial. 3354
`WWWIHWFUIWWMHFSIS 2003.8Natiowlde
`Survey in Hospitalized Heart Falkte Patients h lereet. 3134
`B-type Natrluratic Peptide Level Maestro on Admission is an Independent
`Predictcrol Long-term Mortality diuPrirrtary Angiopimty in
`ST-eiavatbn Myocardial Intuutlori. 1623
`B-TypaNatfluraficPeptideLevehOhnity.mStflhalinMyanoad
`Heart Failure. 2582
`Baseline High—Sensitivity C-Flelctlire Home Otters Prognostic Vania in
`Addition to Contemrary Enumeration in Non-ST-eegment
`ElevetionAmteCoronarySynd'mn: Heerfllaflnrntl-ieCURE
`Inflammatory Marker 51mm. 2343
`Binge Drinking and Modeller Foiowing Adria Myocardial Infarction. 3438
`Both Abumlnurta and Frantngharn Flick Score Predict Cardiovascular
`Events In Nbuninurlc Sibiacta with intermediate Cardiovascular Rink.
`3850
`Cei'diacOUlDiflRaepomtoEmcleeendMonalttyinflieB-BbdierEraot
`Heart Failure Therapy. 2611
`Carotid Inthra~Madia~Thickmee Predicts Cardiovascular Events in
`Subjecta with Intermediate Cardiovascular Risk. 1787
`Carotid Plaque. Net IntimaI-Media! Thickness. Predicts Clinical
`Wm:hsmngHeansmdy.Sfiafl
`Circulating B-type Natriurettc Peptide and tit-Terminal pru-B-typa
`Wuretic Peptide a Matter: o‘l Lung—term Survival In 9atiart‘te with
`
`Supplied by the British Library 24 Apr 2015. 20:23 (EST)
`
`UNITED THERAPEUTICS. EX. 2096
`WATSON LABORATORIES v. UNITED THERAPEUTICS, IPR2017-01622
`Page 216 of 262
`
`
`
`E
`
`i
`
`
`
`
`
`III-1050' Will Circulation VoII‘I'fl.N017 October26.200#
`StaoIaGoroltuyNtaryDtaeeee.32e-a
`Hyperthar‘o'ialoliowlng RepertoeadAculaflyooudlfltnt-roflon a
`mmmdmwmemmmmm
`Associatedutth EedyLeltVentr-ioular Harnodellng. 1610
`wmmowmmamr
`Hypoalbun'linernlalaaFraquant FindlnglnLaanaaWallanbaut-taart
`Failure Patterns and Independently Predicts Mortality. 2686
`CmEndomdaIDyafunoflonProvtoeeMplaMeraeProgmaflo
`ImpactoiBodyMaeelndanonCardiao MortalityinPatlentawtlhKnownor
`ImmPatIantaWithroneryMeryDiaaeaaDuflngLono—Tann
`Slnpected GADUndarooing MyooadieIPerflsionSPECT. 3131
`Folew-upOwtflDMomhaBtae
`mmmmmumdmmum
`Wmalmmlmmmmw
`orpmwmmmm
`andOororlaryEMSBSS
`DayaonlnmvaeoannPredlota‘mromoooytopanlaandDroph
`ImpactolfiwaaouanzafionProoaoureelnmaSubacutaPhaaaattar
`PlataiatComthepannPredlcteMonalltthlndlngarronttha
`STéiagmant Elevation Myocardial Infarction on 1-Year Mortality. Fleaulta
`WWWWWMHmn [CATCH]
`ottt'raAOOS-Ftegiatry.193?
`WinLaflVuflflodarEjaaionchflonAflerfi-Bbokmlam
`399%.???
`WWWWWWWWNS
`Independent PradiotorofSu-yilmt inPatierrte with StabIeGoera
`HeertFeliwe.2593
`WWWWWMWEMEMQ
`DepraeeedfielatlveLyrnphocyteCotmleAaeooiatademDeathln
`Improven‘lentotStreaaLVEFratherfltenRaatLVEFlnPaflentauflht
`PatientevldthypatmphicCalfiornyopathyJaOG
`Isci'lel'nic Gerdlornyopathyanotriable Myocardiun-l. 1998
`DepueeimtaePradiolorotCa'diovaacularEvamaaflarccrorwyAnary
`ln-hoapltalandOna-yaar MortalityofPaflenteMtoDaveIopWoraanhp
`wmm
`mrmmmammmlnrm. 1354
`DepmedveSymotomaAndOuaityOtUleFradlotShofl-TannMortelkyln
`Incidence. Prevalence. Md Prognostic lrrpactOfPulrmnaryArtarid
`Pa‘tim‘lathhChrorioHeartFaiurmfilt-B
`Hypenanuomn Population-Band Study. 3423
`Detarrnlnanteoi‘tri’ear MortelitylnPetien‘lewithStaoieAnglnaarldFlrat
`Increeaed Muscle wmpathafic Nerve Activity Predicts Mortality in Heart
`More Patierrte.393
`MWBDIegnoalaotCAD:fiesuitsottheSTARHeniem/.2915
`mnnmmrmummmmm
`Inoran-lentelCIirloalValuaotChengaaintheDopplorMyocardid
`VatvaRaplaounaruloerrticStarmiaAtS-yeu-SMJSBIa
`Patonrlanoalnoexnunng mummy:
`Dllt'lniahedEalcacyorAanaHaperrmmTherapyln Patientawtttl
`Association with Neuonon'nonal Activation. Left thrIcuiar Remodeling.
`ST-Seament Elevation Myocardial Infarction and Advanced Baseline
`and PrognoeieN‘ter Acute Myocardial Infarction. 24-01
`HendFailmJBSS
`Imrarnental Pragmatic Value of Contrast-Enhanced Dobutarnlne Stnaae
`WMEflIocerdlopiaohyaaeProgmaflomdDiagnoafloTooi
`thocardiogrephyhthaPradbfionolCardbveecderOutoornehtHaan
`inPaflmtaMfltEr-dStageHanalFmedaes
`TMHWZM
`DoesHid‘bSenslMyGfiaaofiveProtelnProvideMdiflonelPW
`lndaoer'ldalflw'ldlnormntat Prognostic VatnoiEarinitralAnnuluo
`mooninPafientawifltHypananaionandLaflVenm
`velocity In Patients with Impaired Lari Ventricular Systolic Function,
`2N1
`mum-Emotes
`DoaelnepomonataEIreloieeBloodPraawafiaaponaeInl’afientewlth
`IrldaonCoroI-laryclrcutatoly FunctioninflaaponaatocoldPraaaor
`ControlladHypertanaionPredctaWoranuloomatasou
`Correlateawithcalculated Framirlghamci-IDFiiaIlSminMenwllh
`Doeetru'ObefityPuadou'EmndtoPaflenaMhNon—ST-Sagrnanl
`MataooIIcSyndrornaGornpu-lente.3050
`ElevationMyocerdIellnlm? Inaigltttrornmatiiationelfiagielrylor
`InnavmouaNioorerulbaloreRaoameionlmprwaaEpicudlelFlowrd
`Myocardiallntarctlcn-tfitlm
`Accelerates ST-Sagn'lent Resolution in Patients with Anita Myocardial
`mmrthfimmmMMImlmmm
`infarction. 3070
`Manama
`IronStatmieAttenualaoin Patientawithcrlroniol-IeartFeilureano
`WwaWWmhmelnflowlem
`Asaodl‘ladlttthlmpaireo ExercheCaoadtymdSmlvalJndepandent
`mmmulnwmm.m
`oiHemaglobIn Levels. 3475
`Marmmmmmlmmmmm
`la Myocardial Performance Index Better Than Ciaaeit: Echocardloorephloa
`Intarvantioniorr'loute Myocardlellnlucticn.3232
`Markeraot Mortality inChIldreo with Idiopathic: Dilated
`EIaotrioaIAeynorvonyDoeaNotAIaol‘ihaSlnrvalotHaenFallure
`(Immunm
`rim-113.3331
`LaokotLettVantl-lculerOIiatetionlaAMa'tlerOrlnorauad Mortiityln
`EiavatedSeIunCyataflnCLavallaaPraduorotcardiecEmtain
`PafiantaiflflthGflonioSeymMihaIHegumflationandNormfifleoflon
`CI'irorlicl-Ieafl FeiiuroPeItierrIthhNorrnaicroe‘flnlne “.3341
`Fraction.“
`EvamuonandOuwomeeotmmocytooanlaDavelophgwmlaon
`Long-terrnBranefrleofMontapieeePl-klrto Coronary Angbpieatyhm
`HepaflnAmorlgCerdiaoCareUnit Patiantaflnalghtatrorntha
`Myocardial Infarction: RemindheCon‘bIningMontapIaaewilh
`emphatic-antler Thrombocytnpenianaad by Heparin [CATCH]
`ArglopleetHOOMA} Trial. 2111
`fiagietry.1rer
`Long-Term MortalityotEerlylnvaaiveWnentotAcutacoronlry
`Evalutionothg—TerumgmeleotVenoicluarthfitwruanrbkuflng
`Swldrontea Without ST-EIavetiott: a Garnula‘liva Mata-W. am
`frornfiight Ventricular Outflow Treat (HVO'I').3215
`Long-manoomehPauantewnnSIIemymSymotontaflclacnen'fla
`Evidence-Based Ftiak Stratification Ia NolOptlrrlaiiy Used toTaruet Proven
`during Doblrlernina Straaa Echocaroiography. 2538
`TharapiaainNon-ST-EIavationAmteCwurySyndromeacTneGiobal
`Long-TennDutocrnaaendThaerraoioioreartarHoapflaIDlaohargeloer
`HegleuyornouteOoronaryEvamatGFlACE).-‘505&
`Inmmmcmmmmemayicw.m
`Fronoangedeayndromeflegish‘thOBRfilltDaaiwiaIfltaSmy.
`lang-TmnSafetymlenloaIOutoomaaflarlno'aoomnryProgu-flmcdl
`PrIIIn-llnlry Results Gamma Demographic. Clinical Demand
`Transplantation In PetbntawlfltActrtaMyowdldlr‘flmoHom‘l Year
`Foilow-Up.3210
`Follow-Up Analysis of the TOPCARE-AMI Trial. “48
`movminmrammmmmmmmgmmn
`Long-Tenn Survival altar Paroutaneoua Coronary Intervention for Chronic
`Newman
`Total OooiuetoneJBEU
`Hud-fiatafleoovaryhtterCardiopuh‘noneryExercieeTeefingPradcta
`LowLavelaotPiasrrlaAdponectinConoentratmaflaeruta Myocardial
`Mortellty lnPatim‘te‘l'ir'it‘h CI‘II’Dt'iII: Haarl Failure. 229?
`InfarcflonCenBePotantiaiiyUaadTo Predict FutureAdveraeCerdiac
`Heart-Type Fettyltoid Bindlng ProlelnPradlotamaPropnoaiaotPatlanta
`Evanta.3234
`wilhAortloVelveDieaeaee,3232
`Malt! Prognostic Hole of Admission Glyoamle on all-day and 1-year
`HamogioblnLavaiaPradlolsllrvivalandHoepltalizatiothere
`Outoornaa In delabetlc Petierita admitted for Myocardial Infarction:
`Complicated Awte Myocardial InlarctIort: fiaaultatrorn theOPTiM-AAL
`Flaauilatrornthe Nationwide French LISIC Study. 1851
`MJGFE
`MatrixMetalloprotetteee2«AStonuProdictorofhW|tyafler'Now
`Hermiobin-retated Mortality in Patientawithhcu'telilyooardal Infarction
`Datinition' Myoca'dial Infarction. 2574
`Undergoing Primary FarmlaneoueOoronxylnterventione. 26?1
`Metabolic Syrdrorna: a Mel-or and Independent Predictor oi In-Hoepltal
`HighPramnInmeFelaaLun'lanFevoraSeoondaryOIIalafionofme
`Mortality and Cerdioganio Shock In Pallantawtti'lhoute Myocardial
`AortaWAoutoTypaAAorfloDinoctionJitfl
`Infarction: Data from RICO Survey. 3060
`Highwm (‘rFieective Protein: Potential Miami torFilalt Stratification
`MinalfiegwultafimflemeinacornmonettarMyocadlallntuwmmdia
`hPauarnautmlacharrlicoermicWerl-leanhlm.
`3471
`PowertuIIy Preemie olAdyaree Outcomes Despite Ranh-thioter‘lein
`System Biocitede: DatafromVALtANT. 2650
`Highu‘ Preprooedural ”mph“ Countie Independently Aaeooieted with
`Myocardiel Characterization by Magnetic Raeonance Delayed
`DeathorMyocerdial infarction in Medlcailyn-lanagad patients Following
`Wmlam
`Hyperanhmceroent Imaglnosuonalypradiota MelqueraeCeroiac
`Evarrle.2985
`HiatoryotSyatemicHyprlanalonlrloraaaaathaFliaflotMonality.
`MyocardiatcontrmtWWWIW
`Thromboticantifliaadinpcomolicatlona Following Non ST-eagrnant
`ComparedwrththefiMIScoraInPatienta PreaentingtothaErnerganoy
`EiavafloneoulacaonarysmromaJmG
`Department with Suspected Cardiac Cheat Pain and a Nondlagnoatic
`HomooyetIeMCerdimeaouiarHiakPredctororMInorofHenelFuncflon?
`Electrocardiogram 1606
`MMMWMJM
`N-Tarrninal Pro Brain Nltrluretic Peptide Predicts Long-Term Mortality In
`HOWIn'ponamiaGomplataRevaaouiutzattonattrMyocardlallnfmction?.
`3074
`Stable Coronary HealtDieaeee.1950
`
`Supplied by the British Library 24 Apr 2013. 2023 (BST)
`
`UNITED THERAPEUTICS, EX. 2096
`WATSON LABORATORIES v. UNITED THERAPEUTICS, IPR2017-01622
`Page 217 of 262
`
`
`
`MWMEWEWWWFW
`DiabeticEtrdulinn.2tlB1
`_
`mwmmrmwmmmm
`Following Incldem Atrial FIbrlIIatIon: Daiafrom 2 DecadaaflBtiO-emm.
`2976
`PataicyolFeleeLumenofiheDamndngAertaleNotNlaredByan
`mammtIHMaTypenDlssmflon.2?«
`mwmmmmflmmm
`Higher HIekelGerdioveacuiarEveniaHhaNorthemMenhathtudy,
`3611
`mmmmmmmmmemmrum
`mmmpmmmmrme. 11'5?
`mmdmmemmm
`pailentawllheflieroaole'oeie inmltiple vaecularregiore. arts
`muweormemmmmrmm1wscsmu
`MolaielhePrognoethlmoaciefPlaomtal Grth FactorinPaiteme
`PoetMyocerdlalirrle'ctlonJeez
`Poemardloreeplratoryfirreetfiohocardmphy Variables HedictOutoome
`mmom
`PredicthghlortaiflylnfiunrivoraflthcuieComnuySyndromeUelngThed
`DmgtemSoorezniekseafiflcefionByDbchugeMedicetm.M
`PredichmmdLong-TmOutoormotMatorBleedh-glnPaflenieMih
`Nam.aweummmmsm:mmmn
`cmmmmmmfiegletfieejm
`PredictoreofFIve-yeuhiorialhylnPafiameUndorgoingPrrnary
`WWWIWFMMW
`Win Myocardial Infarction [PAMl] Triele.3512
`PredciomolLong-TemuonaityinPaueniswflhmendoce'difia
`tlE):APropenetiy8ooreAndyeh.28-tfl
`mmmmmmmmmm
`WMHIYwhmHMW
`WdewingmmCmrySyndmmem
`WWWWWM’MWWW
`www.mee
`WMWWIWM‘TWWMWW
`With Smitty-m Myocardial lnm. 1324
`PrevalmdeoephalOuicomeeotMuiaHeartFeimNorLafi
`VentricularSyetolichafirmeonOompucmncutecoronary
`mmr
`PrereimoniAnerniaAmongHeaflFMPeilenbeWflhPreeewed
`WFWWIBIWWMWJW
`wmdmmmmmmmm
`Nori-ST-EimtionAouteComnai-ysmdreme: fienltsotFollow-up For
`WYH.3877
`PrognoeflcSlgnlfloanoeotPlaamaLeveleotHepatocfiaGrowflaFactorh
`PailentaMIhCongwiiveHearlFelmm
`PrognoeflcSlgnlflcanoeotSilemMyocardallaohemieDmEmrciea
`smrmngdsm
`mmsemum-Wmmmsmncmm
`ECG GroupainiheGUSTO-zb Trial. aunt:
`PrognomeValuentCa'dloputnomExercieeTaathglnHmFellure
`Paum‘iawrm Preserved Systolic Fmtxion.249?
`WVaimotCarofldPlequeWpl-iologyincudkflogymm.
`2064
`ProgrweficVebeotClrmiafir-gShedWPm-Cmn
`Microoa‘fldeehPesimwhhSemAcuiecoronarySyndromeeJ
`SWFromflieelobeinagiazryotmmcomnuyEwflelGR-RCE}.
`2676
`PrognoallcVelueotGoneoiedJTe-HOTIMM
`WWmmmamuwmmmaHm-Tmrmm
`Binding Proheinln Heart Failure Patlente withPreeervod LettVantrioular
`SystoflcFunction.347iJ
`Prognostic Value at Endotlhelln Peptides In l-Ioan Failure: Resultsfrorn
`VI-Hel-‘IJHZ
`WValmOthmflveCardiachporflanorPafieme
`UndumingEiectlveCaoneryAneryByoeeeSwgary.2208
`Program Ventricular Stimulation la Aesocietedwith Leno-Tm
`ammunpaaemsmn Nonlachemic Ditatlva Cadmmyopuhy Treated
`withmlmplmla mmmlwor. 2240
`Pul'nonaryCapecitamePredIciaMoriettyin PulmonaryHypariene-ioo.
`2641
`Pulse Preawre Predicts Survival In Advanced Heart Failure lrdependent oi
`Invasive Hemodynamic Mamie. 2809
`ReducedCaumFwaeeamonLefiAnterlorDeaomdingMery
`Wm Prognoele in Patients With Positive Stress Echo by INell
`Motion Criteria; A Trarlslhoracic Vaaodlla‘lor Stress Echo Study. 2219
`Relationship Between Malcolm Glucose and Mortaity in 713 Diabetes
`Patients with Acute Cannery Evans. 3749
`Relationship of Renal Ineuliiclmcy to the enemy oi Non‘SFSegn-ient
`ElevetlonAcmeGoronarySymmeeCereandOmoon-reszfiesulis
`From the CRUSADE Initiative. 361?
`Right Vanriculer Dyelumlon In Hypertrophlc Card‘ionmpalhy: Prognostic
`Slanh‘im at Dom-Derived TEI Index. 3145
`Flight Ventrbuler Enlargement on Chest CT as a Predictor of Mortality in
`Acute Puln'mew Ernhcrliern. 2am
`
`Moot lm Ill-1051
`WIVmWBmIWWdM.HM
`FaE‘uemdSholleFoiloudngMyocerdieilntercflomWVm Echo
`Shady.2?5a
`FtiakseaiilicailenfanaflmtaUndergoino PiannedEiecthrePerwtenewe
`WIMMIngPime-WPm-B-wflamurefic
`PapildeM-proBNHAaeayMCIopldogeliortheFlecucuonoiEmta
`DuringObeervationtCfiEDOJSubfiudyim
`FiiskShalifloatlmudngaOomhlnaiion otHBaera FattyAcld Blncfinu
`ProteinmdBralnNatrIureMPeptideinPehntaHoapltallaedfor
`CongeaflvaltaenFallure.1?54
`Roleoicoronaryl‘iow HeeerveudfliCmoeet-Erd-ianoedflobtnantlne
`mmmmmnmmm
`orSuepwted CDI'OI'LBI'Y Artery Disease. 328
`mammmnmmmmmKnMu
`Wmmmmmomphy.m
`HoieofN-TmndWMHlekAaeesamentflManagen-untof
`WmnuyEmbollem.243-l
`HolesotfiatneeeandfitneaeaaCardiwaecularfilekFactontoer
`AHepodlrorntheWomen'eleoheniaSyndrmEvaluaflonJflQ
`Serum Mab‘ixMetafloproteheaofluanlndeper-fleanredkfloroiFutum
`CarolecEventeln Patter-itawlitridiopathic Dllaled Cardiomyopathy.
`3142
`Sax-agalnieractionaflarMyocardlal Infarction: Innacton Hospital
`MortalityandbyearSwvllefiZZ
`mmmemmmmmmm
`wummnympmemiurwmm
`SPECT: WWN17£91 Patlmte. 3170
`Specialist Training and lrnplennntatlonol‘ EWBeaedCare Follawlng
`'NewDetlnhion’Myooardleilnfarcflon.m
`mmmmmwmmerm
`WerPredlcilncreeeed Mortality In Dilated Gardiomyopzihy.2563
`SqualPauthomfivelyTreatedPafientanmSavueMflc
`Slenoeia: WVuieblee has? Patients. 2555
`mmmmmwm-Tmominmmm
`SlabIaCoronaryMeryDIaeeeerPredlctiveVeheoifiouiineLaborflory
`Moeaurernenta.325?
`TheAeaodaiimollne-evenmaMorphlneUaaandOutoomeehm
`GoronarySynorornee: Fleeurleirorn UieCRUSADEQuthy Iliiprovamem
`Inlll-atlwe.3056
`TheOorreIallon between Iodine-123-Betarnaihyllodoptmylpontadaclnoic
`AddmdSmmLMBniHm-TypeFaflyAddfilndeh
`PatlentewImChronIcHeenFaiIure.3lJ4?
`TheLong-TennlmpaclofSoclalDapthmionDnI-leanFMA
`memoszs
`mpmmdwmmmmmmmm
`Myocardiailnfarctton.3565
`The Flight VenetulerMyooardlai Pal-romance Index Allow Powerful
`PrognosticPWinPaflentewMWWivefle-fl
`Failure.2755
`TmDahy-MhmdSuMulBe-ehloimmmflmbdyeieln
`Amie Myocaroial Infarction: Influence olTimeI'rernSymptnrn Oneal.
`2512
`mwmmmwmm
`mwwmnemmwmmmw
`Wmfia‘lfi
`Total Cholesterol. Stalin Therapy.end5urvlvelhlediehlcand
`Nmmnmrwwmummvmjsee
`Twehre-YearChangee In the ManegementotAcuteMyooen-llel Intarcilon in
`mmmmmmmmwmmn
`Selma-915
`Prustacyofln
`ClinicalAaeeeamerfloithePoeiMthlcEflectomeyclhAneme
`inPatIeniawtthPulmmaryAmialHypaneaelonmnumm
`Sireiru'Sh-ain Rate Study.83i39
`cox‘z Inhibition AttenuatesWin Expression In Human
`VmulerSmooth Muaolacmafis
`Enhanced WWFMWINWOI
`Cyuooetyneneee-zln Har-naterk‘ianoiaeinmo.352
`Genetic Disruption toOonomtygenaee-z InceaaeeflieSmoapilfllllyto
`Domruhloln-IndrnadGudiotmdolime
`Hemoglobin LavelaanciPuhuomelel Hyper-Won. 2800
`mmmumvmmm Dverioadmdthe
`Elieci oi Eeoproetanol Using Gated [“Flfluorodeoxyglmoae PET In
`Paileniewi'ih Put-nonaryl-lyparienaim. 3054
`Nuclear Factor-ea ia a Target of Peroxieorna Proliferator-act'weted
`ReoeotoryUgandshiiielrSuppreMveEl’ecieonSlW
`Stress-km GeneExpream‘on and Release of Novel Vaeooonairictor
`Coupling Factor 8. 11M
`Prostaglandlna Mediate theWm Eilecis otAtorvaetatln
`Agatha: Iechemla-Rapormeion Iniury. 515
`ThrorntioiaineIt.l HecaplorAntegoniemano Selecovelmihitm of
`WW 2 In Alharoeclmis. 343
`
`We
`
`Supplied by the British Library 24 Apr 2013. 20:23 (BST)
`
`UNITED THERAPEUTICS, EX. 2096
`WATSON LABORATORIES v. UNITED THERAPEUTICS, IPR2017-01622
`Page 218 of 262
`
`
`
`mmmmmmmmammm ,
`DevelopirmtoihotmcororwysmdrunemoiabotioPatieniezn
`'
`Potential Robin Immoinliam'natory Reaction oiPtaque Instability.
`3751
`IdenufloaflmoiTmnamemumtmomssaNovdfieguetorot
`Collatersle'fliJDw
`WotmsUHQuiun-MWWWMWCW
`PruethadimMyommm
`InsP,HeoeptorsinVenbiouleryocytesamPrirnanlyhiheNucleor
`Envelope. AssociatawlmcaMKlla.“ ens Phospl'iorylaii‘ion Targets.
`I’fiD
`mm-zmmpnomnwmmnspzmrmuamnn
`domtlnmmMyocadalesmtolnfmfion.31fl
`WWWIWWMW
`Syetnnmoleolnesofivaowoensmcieantafi
`PlirntioylaflonOtABGM IaflequlredForIIsNormslTraflckhgToThe
`PIsarnaMambrsnsAncl For Lipid Emu: Activity. 1305
`mnmdmmmmmim
`mmmmmmmmwm
`ProieornioeProiethtm
`WMHKP-flmyssauecnmtorimaasedmrwwinwoes
`WQoiaseKrmhoutMioa. 1384
`Riohg LevelsotC-HP and PAM AfterPlaquo DbruptionArsAssociatsd
`wifli‘l'hrombosimuflfi
`BoleotO—GicNAcinPIatoIstActlvmkinmdFumm
`SoyProthupqunmflmemSmmupdsmWoi
`Haridornizasdcontl'ollodTrlsis.3563
`SynergleflcEfieclsotPKCPnosoMMstlonoszspeao-GWW
`Trooonln Ton Crme-Bnooe Cycling Fists. 1233
`TheEnoothslIsl S-Nitrooo-Proteomo: Mitochondrial Localization andemet
`Prolahldfl'i‘flm1591
`WWWWCIWMWWWGW
`{COJActivnyWslntersotionsWithThaOONSubtfltlncmuo
`Preoonditionhejofl
`WhydolhsPulrnonary VolmShowN'rhythmogenoeloZ 1398
`WI: enzym-
`Laeional Overuorassim of Matrix Metaloproteinsse—B Promotes
`ImaplsqueHamonnageinMvsrcdessionmbinrmmEflersm
`ointhemgenssis. 1181
`AFmflbmgenioHoisForMMP-QhMt‘nroeciemlsThmughAoflvaflonot
`TSP-fl. 383
`Age-depenmcnmgoofPlemeMemenioalswhu-dfit’ummels
`mMWntMMP-mwfimmot
`Matailoproteinsse-t lTIMP-t} In ApoE and LDL Receptor
`DoubIe«Knookout Mice. 591
`Bionaaio Regulation of TI-iloredoxin by Reactive Oxygen Species {H05}:
`Immmtmmnhmwcdlmm
`Changes in Specific Mstrbt MW Levels and Fibroblast
`Function Aooompenytl-ienge-rslsied Inmin LVMsse. 975
`Chronic Matrix Motslloproisinsss Inhibition following Myocardial Infarction
`in Mioe: Differential Elects on Short- and Lona-Term W. “375
`Const'rhitivelyiflotivn Cruise Matrix MatailopmteasoZExpmssionDrivoe
`Dyet‘umtioml vmfiemomung InTraraganloMioa. 1359
`DagmdationotMyothghtChain1hlsotatedRatHearteSubjecteoTo
`Isohemia-fieputuelon Inlixy: A New tntrsoeiiulsr Target for Mam:
`Metalbpmtelnsse-2.2959
`DllmflsiEfioctsoiSmProusssINfibitorsonMMPReleesein
`Patients Following Csttiioirlulmonal'iiI Bypass. 1712
`DilerentialsteleottneMetalioorotssseDlsintegnnsln Patientewilh
`ted-amlcorDIstsdcwiorflyopaWHelafloniolntsg‘klProfllesend
`MMP Mthration. 2093
`Dysfunction oi' the Ubiqultln-Proteseome System Is Mmpenied by the
`Accumulation oi the Proepoototio Protein SmeleABLO dunno Leit
`Ventricular Remodelbg. 1?
`Early Exacerbation In Regional Myocardial Remodeling Following
`Radionequmnblativalniuryinwoe Del'lciantinliitmit
`Wuhan-3.2333
`EttaotochMP-DepenoantProtsln luneselonStamceilMalntenmbm
`
`
`III-1052 Wilt cm Wt 110. No it? Octabsr26. 2004
`OOX-ZlnnbltionAtierustosTlnombunoouflnExprmbnhHmsn
`vmsmmmasa
`mmmmmzlmmwm
`Maui-WWW.“
`mummpmummewm
`W.m
`HmOxygenssedMedataeFunctlondfieadefimoiProetaalo-idh
`whmmmmmrm. 1355
`mammomrmammtmmmw
`Hypsnension.1414
`mmamummmmwwmmtmmm
`PhosphorylaflonotFooethedoannassa-IdMWonianiisr
`mmm.1321
`mmmmumwh
`msmmmmunmmmamnmowm
`W18“
`OversmoeslonotProtshHufiaesBasIsotCyolooxygoneso-z-
`wmmlmwmnmmwm
`Wmmmmmwmm
`MWWW-CPHW-CPRJ. 1632
`Pmotaglandlm mmeimmoiapmm Electsde
`Against ischemie-Haponuaim Inlunr. 515
`ThaMiru-alooortlooldfleoeptorfilookerEpteru-Ionelnhlbth
`W2MWTwe1mGon-Em
`ammuwmwm
`inmuoe
`Thrunbommhfieooptmkmgonlunsndaelsctiuelnhiblflonof
`melanoma-i3
`Wm
`AWTMOonWigs-mmmwvmm
`SientedifaNeehtMAortioPositiontASSBfiJfiSfi
`mwmmmwmmwm
`maSnndardimodAnlmsiModdofMoflchlendowdlflsJfi?
`AmniotnaflS-Yesr-OldWoudetTheeMschuioeiH-anvm.
`200?
`WHIMIWFWMMWWW
`mmmmm.n15—mm.asa1.a
`MWdTWVsMWmYmWMMm
`Ell'sotsoiProathade-Pstlenthlismswh atleerrtli: Volvo Fleolsosmenton
`mvmmmmmmwumm
`ImpsksdPreopuItIvoLettitrlwiarFunction.2559
`FWNWWMWWM
`MedanloslProstfueuL-aflettsiuoflonbyfianstnomoiceno
`Tmmmmhswwvm
`Dyetunctlon.‘l?21
`Long-Temotmonwsoivmfloplsoontemwmiuodsmprosflieeesh
`YmMuMZSSE
`MloaflmOthnWGflsByG—GSFWIW
`HeapomehndGaicifloatlonslnDeoelhflludHeansivesJfiBa
`WTWWWMWVMWH
`Geloifloifloniosmnoeie:3~Monti1FlooulteottheI-REVNEFfliot Study"
`2067
`PreoperativeCholssteroiLwelaDoNotPredlctStimtmaIVam
`WhPatlenteUndemoinnBloprootl-ufiomvm
`mazes
`Prosthesis-Patient Mnstoh afiserrIioVslve Replsoimnt: Impact of
`Piooperalive LettVonn-louisr Function on Clinics! Outcomes. 3275
`ThsCflnloflandEoumiolmpactotStaptwooommsfidesm
`pmammmowmaeae
`Pm
`mm lni'llbi‘tscholeetorol'l’rsmpm By High Density Lipoproiein:
`Potential RoleForSlteSpedfic Modification Offioolipopmtdn A~l In
`Athemganoshm'i
`NMlionsoiProialnTunoverDurlngiheTrsnsltioniromStable
`Flypa'lrophytoHoenFoIliuismti'ioDogm
`Autophsoy.s$uwivaihteoharisrnincnroriodlylsohomiouy0csioiun.
`1424
`Braoyldnin PreoondllioninglmomesthahofileoiasdPhosohorylsflon
`mmammmcmmicmfios
`WWIqumwmmHe-mm
`ummmmmmmmmmm
`nominees
`CsrdlohophIn-1PromotesMomcfioCtmmotstsThrouohAothiafionoi
`MonocyieChsmostflaotsntProiaimt In Human Aortic Endotnellnl cells,
`was
`CW1WMtivaflonoi‘ lnterlauldn-‘lB by Matrix
`WusfloflWmeJwa
`DirectfiogullflondSEHGAAcfiuityhys-thsmfionatmefluby
`PeroxynltrlteJZ?
`Elin'ina‘timot‘Hopbflj Hem-Shocthmmflqumand
`ImmW‘WMWmmWiW
`mmmminmmmmm
`FollowingLeflVentioderAsdflDwtoeSuppoflJBSfl
`
`notMobilization1560
`
`EflsctofflieG—1562TMsb‘thetelloovotolnaso-9PrornoimPolymoronh'n
`onNun‘ioerandFmoflmoiSiernaridProgenitorchshPafimtewlfli
`Chmnioloohomicl-tosflbismmiflo
`FurhsnoPOSareLoosiizsdh'iMeoroohsgesfioemcallelnHum
`AmaroscierotioPlaquesendareFtequlraotorlntegrinavand
`m1-MM9AoiivstiothE-i
`loonflfiosfionomenenWioumtaesomsuaNovslflegumoi
`CollatersiGrow‘th. 1M
`In Vivo Detection 01%;:de NMPMMP-S) In
`AtheromluoticMiDo.558
`Inhibition ot' c-Jun til-terminal Kinaao Prevents Devebornant ot Abdominal
`mmminammmjer
`mommnoinnmmmcminmmmmm
`212
`
`t
`
`i
`
`Supplied by the British Library 24 Apr 2013. 20:23 (BST)
`
`UNITED THERAPEUTICS, EX. 2096
`WATSON LABORATORIES v. UNITED THERAPEUTICS, IPR2017-01622
`Page 219 of 262
`
`
`
`lmoNen-lentofthepmprolahoomenaeeFulninlheamrlalmto
`mama
`LeflVenMouIarDyaiunofiona-tdfiedmedwmmmted
`Over-Emmi of Membrane Type-1 Matrix Meialiopmtelneaa Mloa
`WWWJsa-t
`WWSWWWN
`PfornoileeMadalEroeion.1a15
`MammaflonandEngreflmemomemopoletbSlamchaMHnme
`WIMMWIWMdI-Iflflx
`Melalloprotelnaeee.2331
`Maire: Malailopmtek'laee—QGenaDelefion lnhlblte FormationOlMul-ine
`Thoreolonorflonneurmaflz
`Membrane Trafidllngol'l'haMernbraneType-T Maid): Meialhproteinmh
`lechenieandflepedueion:fielaflontolnmflfldAcfivity. 1056
`WIMNWWWMWCWW
`Cudhpleglmm
`hm-MMP—DependentNeoveeeelFomlaflonwimmmeConfineeofflie
`mmmm. 1458
`WWWMWTweJ Matrix
`Memoorolelnaeemaee Wm Cald‘lon1yopethy.2m
`MomofPoellsLaadetou-wFonnaflonolanLDLR-Poaw
`Gornpiexartdnooeierathnoimoegtedaflon. 1W1
`WMdWM-wwmammmm
`Myocardial Ieohernia-Repu‘helonlnm. 1278
`PIwnaProfiieeoiMebixWekm-emdflmlmblmol
`Mah'IxMeianoproteh-leaee:cherlgeeneeociamdwlmmePreeencaol
`DIeetolchyehnoflon.28E3
`MmmwmmmlmmMmea
`Whmmmhmmu
`Mioe.2950
`Pmtaeeome Inhibition Reduces Endothefial Nitric Oxide Synthaee Function
`mayhem-roman
`RobotEpldenfldGmrfliFmHemohorTram-acflvaflonhm
`ammneeeDomegtlatloan-igueutmpmlcmhepeln
`G-il'lduoedMyocy‘heAnoileJM
`RoieolProieeaeeiorTmlmaeionanoNeoyaeculanzaflonMed'madBy
`www.mo
`mmmmlmmmmumm
`mmmhmmmmmm.
`3100
`ShopmkinaeaUndergoeaAutopmleoneielhatReduoeeflmeEmolenoyof
`Piaamb'logenkfiveflon.m
`fileEMofMMleflfloanMlamWhm
`ImphmmledDunnglheLoadedwauameUnIoeoedSNan
`mummmmmwmum
`SymhaaelhrwghaSm-WWPMJS?
`Tramgenlo Oyaraxpreealonol'mlGF-l lmreaaeeSlteieiei Mueole
`PhoephorylatimuiFOXO Forlthead Tmecrlotlon Factors and Blocks
`Expressionol'fllanIquIflnUgaaengIn-‘I thnEVen‘Ifioular
`Dysflmfion.210
`Hm
`WNMdnmemmenomm
`Hypertrophy to Heart Faliure IntheDou. T93
`Degradationol'Myoeianal-rtchain 1 iniaoilledFIetl-ieertsSubiectedTo
`lechernia-fiaparnleion HurANe-wlntreoehluTwetforMah-Ix
`Meielloprotelnaealaflol!
`IdenliflcabonofTrelwnembranoua Protaaaon‘leaaaNovaI Regulator a!
`www.1m
`Moo’flbailone to Trooonin c with amt lechen-llal'Repel-iuelon Injury. 1541]
`PWDvmoandNalohmnoralmwaflonDMfiaflyamme
`Myocardial Proieorne. 1264
`ProtectrficandMeiabloiomioAnaiyaleRwefiaCmolelRoleofPKC-filn
`Cardiac Meteboflama and Cadloomtection. 514
`ProteunicDIeooveryolCormarykieryDleemertei-etlalrglnduem
`ScaleArlalydeolPooledlena: Reeullsl‘romthePoolodPlasma
`ProteorrllmProiecL 1011
`RairMElQERK Pathway as e Mechanism for lmraaaed Longevity In Type 5
`Monylylmdaeexnockomllilice, 1384
`Tenuoin-c MedaleeleacEnlf-omaial CeiIPnenotypeendfinglogenlo
`Manon-3.104?
`TheC—TenninelolGoanPromoieeDNARepeir. OellDeathand
`Expreealonofapaa-DependeinGeneMlhaDeafiiDon-iaian
`Cardbmyocyiiaa,265
`Palmer-q am
`makapowerfuldndependent PredictorofMorte-Ii‘tyinPatlen'lawflh
`Pulmonary Hypertenalon. 2601
`Bone Marrow-Derived Celia Contribute to Pulmonary Vascular Remodeling
`in Hypoxia-Induced Puln'lonary Hypertension, 1119
`Bone Morohogenellc Protein—r Inhlblia the Reieaae of Enoothelln-1 from
`Human Pulmonary Smooth Meade Celle.1596
`Fumtionai Left Pulmonary Artery Stenoala in Total Gavopulmonary
`Connection (TCPCI: Aeeeeeing Improvements In Lung Perfusion and
`Cardiac Workload with Summer-Aided Angioplasty. 3409
`
`.
`
`mm Ill-1053
`wmmwummammmn
`maybe-lam 1195
`HemoglothevelealioPUnlonalynmneiHypel'terlelon.25m
`Human HIF‘So lean lnflfl‘lorofm HIP pathway Inenootheflal Della. 1021
`mummmeomlnmuoxslmimmmlnm
`mamwmmwmmm.
`r46
`WMEMPRMWBWWMWIH
`BMPRSIarlddeithuuTmMuyEndomellalcels.1471
`HypoalcPulmonaryHyperteneion:RoleoiNADPHOx|daeeend
`W483
`ImpacteifleneticSymmSmglcalCmeofionoleoiFaflot
`3412‘
`In VilleLoeeol' arm Expreeelon byeIRNA-Medleted Gene Silertclng
`lmPlJmonaryHypeflanelonlnRaL'i’?‘
`InaeaaechMPPhoaphodleslemaaExpteaalmhmenonay
`ArterySmoothuaoIeOellehomPatlenteuflthrlmermeona-y
`Hypenanalon.1rrl
`Multideliecbormwlflimrbovdhlaneional RaoonetrucflomEll-aluatlmo'l'
`SW11“: and Pulmonary Vascula‘lu'eandTracheool-onohial Tree In
`Neurbornsar'ldlnfaniaJM
`menpsmxmmmmwmwmm
`ArterieIHyperteneIon.BS
`PatienteWithMimrElevam In Puln‘lonaryArleryPreemeave
`lnuaeeedMoflellty.2?53
`PuhmMaySmoflleCeneDefioiemlnTypenflm
`MorphogeneticProlehReceptorExhiblt GainorFunciieninFiaeponae
`toBoneMorphogmeflcPro‘helnTim
`RasMedlaheAngloleminfi-deoendemlnoleaeein NlhlcOxloewiaee
`Expresdthtamona'yEndod'lelum.m
`Reversible PulrnonaryArlery Bending V1Iniiennlttenix Contimmra
`memoffioate.2m
`nmmwvmlammuonlacmmymm
`mammmeer
`Sell-2W MRI Imaging andTracklng Catheters lorHigh-Reeoiubon
`[me-Came: and Vessel-Wall Imagine. eons
`Bernicnlnlndmflonolsmommm Expressioninl-iwnenPuhmrwy
`AnerySmoomMeGellsloDapendemonboflltheSero‘torin
`Tral'lepcl'teru'ldfiaom.sn
`mmmlmlmmmwmm
`lnMedbyMlnaofivation.62?
`Smad1moilaHumanPuknonaryAnel-y8mooihMueoleCechoilfaefim.
`1323
`$1.1th Targeting Reverses F‘uhlonary Medal Hypertension. 626
`Zaorlnaet MmmADUIIeHy-poxic PulmonaryArleryOy‘tdthaExpraaalon
`andPuh'nonaryVmoonah'iofionJYH
`Pulmonarydrotlafion
`18% Mdetac‘torOorrlputedTornonraphyForEyelmflmOlSimt
`Pmmwmwvmmwammwmvm
`Stanoeie Followk'lg Racilorrequericy Catheter Ablation. 1781
`S—LJpoxygenaeeDaficIenoy PreyenlaReeovalayFeluewWoi
`HypoxicPui'nonaryVaaooombicflmdufingVerflm-mdurg
`Inju-y.119(l
`mmmmommmm—mwmmm
`InPulmonaryVeIn WommolfideHoodflome
`WWFUMWWWPMMM
`Patients WI‘Ih Congenital Hart Dbeaae: A Warm.
`3025
`Brain NmflmerlcPepfideLavelabmthmealarReels‘imoe.
`Predict Right Venmear Size and Fmeiionai Stems in Pulmonary
`Arterial Hyperter-alon.1760
`CaueeolconelerionFalmeBetwunCeroloputnonaryExenolaeTeatmg
`and Six-minute Walk Distance In Pellema with Pulmonary Arterial
`Hypeneneioni2496
`Cell-based BerleTraneferofN'oiopdeth-l HeduoeeAIremoe
`lmmmmmmmmmw. 141?
`Clinical Ellcacy of Oral Bilde